MSK Department of Medicine

A novel CAR T cell therapy for people with large B-cell lymphoma by Jae Park et al. – MSK Department of Medicine

MSK Department of Medicine shared a post on X about a recent paper by Jae Park et al. published in the Journal of Clinical Oncology:

“A phase 1 study led by Jae Park evaluated a novel CAR T cell therapy for people with large B-cell lymphoma.

Of 28 trial participants, the overall response rate was 82% and complete response was 71%. Patients did well on low doses that minimized side effects.”

“Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma”

Authors: Jae Park, Lia Palomba, Karlo Perica, Isabelle Rivière, Michel Sadelain et al.

A novel CAR T cell therapy for people with large B-cell lymphoma by Jae Park et al. - MSK Department of Medicine

More posts featuring MSK Department of Medicine.

B-cell lymphoma cancer CAR T-cell therapy Isabelle Rivière Jae Park Karlo Perica Lia Palomba Michel Sadelain MSK Department of Medicine OncoDaily Oncology